160 related articles for article (PubMed ID: 7710951)
1. Retinoblastoma gene mutations in primary human bladder cancer.
Miyamoto H; Shuin T; Torigoe S; Iwasaki Y; Kubota Y
Br J Cancer; 1995 Apr; 71(4):831-5. PubMed ID: 7710951
[TBL] [Abstract][Full Text] [Related]
2. Retinoblastoma gene mutations in primary human prostate cancer.
Kubota Y; Fujinami K; Uemura H; Dobashi Y; Miyamoto H; Iwasaki Y; Kitamura H; Shuin T
Prostate; 1995 Dec; 27(6):314-20. PubMed ID: 7501543
[TBL] [Abstract][Full Text] [Related]
3. Frequent association of p53 gene mutation in invasive bladder cancer.
Fujimoto K; Yamada Y; Okajima E; Kakizoe T; Sasaki H; Sugimura T; Terada M
Cancer Res; 1992 Mar; 52(6):1393-8. PubMed ID: 1540947
[TBL] [Abstract][Full Text] [Related]
4. Analyses of p53 gene mutations in primary human bladder cancer.
Miyamoto H; Kubota Y; Shuin T; Torigoe S; Hosaka M; Iwasaki Y; Danenberg K; Danenberg PV
Oncol Res; 1993; 5(6-7):245-9. PubMed ID: 8123944
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma.
Cairns P; Proctor AJ; Knowles MA
Oncogene; 1991 Dec; 6(12):2305-9. PubMed ID: 1766677
[TBL] [Abstract][Full Text] [Related]
6. DNA polymerase beta gene mutations in human bladder cancer.
Matsuzaki J; Dobashi Y; Miyamoto H; Ikeda I; Fujinami K; Shuin T; Kubota Y
Mol Carcinog; 1996 Jan; 15(1):38-43. PubMed ID: 8561864
[TBL] [Abstract][Full Text] [Related]
7. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.
Knowles MA; Williamson M
Cancer Res; 1993 Jan; 53(1):133-9. PubMed ID: 8093230
[TBL] [Abstract][Full Text] [Related]
8. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
[TBL] [Abstract][Full Text] [Related]
9. Bladder cancer: allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade.
Wada T; Louhelainen J; Hemminki K; Adolfsson J; Wijkström H; Norming U; Borgström E; Hansson J; Sandstedt B; Steineck G
Clin Cancer Res; 2000 Feb; 6(2):610-5. PubMed ID: 10690546
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.
Ishikawa J; Xu HJ; Hu SX; Yandell DW; Maeda S; Kamidono S; Benedict WF; Takahashi R
Cancer Res; 1991 Oct; 51(20):5736-43. PubMed ID: 1913692
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer.
Miyamoto H; Shuin T; Ikeda I; Hosaka M; Kubota Y
J Urol; 1996 Apr; 155(4):1444-7. PubMed ID: 8632608
[TBL] [Abstract][Full Text] [Related]
12. p53 mutations have no additional prognostic value over stage in bladder cancer.
Vet JA; Bringuier PP; Poddighe PJ; Karthaus HF; Debruyne FM; Schalken JA
Br J Cancer; 1994 Sep; 70(3):496-500. PubMed ID: 8080737
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors.
Gouyer V; Gazzéri S; Bolon I; Drevet C; Brambilla C; Brambilla E
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):188-96. PubMed ID: 9476905
[TBL] [Abstract][Full Text] [Related]
14. Somatic mutation of PTEN in bladder carcinoma.
Aveyard JS; Skilleter A; Habuchi T; Knowles MA
Br J Cancer; 1999 May; 80(5-6):904-8. PubMed ID: 10360673
[TBL] [Abstract][Full Text] [Related]
15. The incidence of thanatophoric dysplasia mutations in FGFR3 gene is higher in low-grade or superficial bladder carcinomas.
Kimura T; Suzuki H; Ohashi T; Asano K; Kiyota H; Eto Y
Cancer; 2001 Nov; 92(10):2555-61. PubMed ID: 11745189
[TBL] [Abstract][Full Text] [Related]
16. DNA aberrations at the retinoblastoma gene locus in human squamous cell carcinomas of the lung.
Sachse R; Murakami Y; Shiraishi M; Hayashi K; Sekiya T
Oncogene; 1994 Jan; 9(1):39-47. PubMed ID: 8302602
[TBL] [Abstract][Full Text] [Related]
17. [The study of p53 gene mutation in human bladder cancer].
Ding Q; Zhang Y; Sun X
Zhonghua Wai Ke Za Zhi; 1995 Nov; 33(11):684-6. PubMed ID: 8731915
[TBL] [Abstract][Full Text] [Related]
18. Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas.
Czerniak B; Cohen GL; Etkind P; Deitch D; Simmons H; Herz F; Koss LG
Hum Pathol; 1992 Nov; 23(11):1199-204. PubMed ID: 1427748
[TBL] [Abstract][Full Text] [Related]
19. Infrequent mutations of the WT1 gene in primary cancers of the adult urinary tract.
Kageyama Y; Yamamura Y; Oshima H; Ikawa Y
Jpn J Clin Oncol; 1995 Oct; 25(5):173-8. PubMed ID: 7474403
[TBL] [Abstract][Full Text] [Related]
20. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]